Cancer Statistics, 2020: Report From National Cancer Registry Programme, India

Mathur, Prashant; Sathishkumar, Krishnan; Chaturvedi, Meesha; Das, Priyanka; Sudarshan, Kondalli Lakshminarayana; Stephen, Shine; Nallasamy, Vinodh; John, Anish; Narasimhan, Sandeep; Roselind, Francis Selvaraj

doi:10.1200/go.20.00122

Cited by 689 publications

(365 citation statements)

References 22 publications

Supporting

Mentioning

361

Contrasting

Unclassified

Order By: Relevance

“…The high mortality‐to‐incidence ratio in both countries is indicative of late‐stage presentation and poor survival after treatment. Hospital‐based cancer registries from 58 oncology centers in India from 2012–2016 reported that 65% of cervical cancer patients had locally advanced or metastatic disease at presentation 9 . Bangladesh does not have a population‐based cancer registry (PBCR) and it is not possible to estimate the trends in cervical cancer incidence and mortality.…”

Section: Cervical Cancer Burden and Trends In Bangladesh And Indiamentioning

confidence: 99%

“…Bangladesh does not have a population‐based cancer registry (PBCR) and it is not possible to estimate the trends in cervical cancer incidence and mortality. The majority of PBCRs in India reported a 1.5% to 6.7% annual reduction in age‐adjusted incidence rates of cervical cancer in the last 10 years 9 . This reduction in cervical cancer incidence is ascribed to sociodemographic changes, such as improved education, increased age of women at marriage, delayed first childbirth, and fewer children.…”

Section: Cervical Cancer Burden and Trends In Bangladesh And Indiamentioning

confidence: 99%

See 1 more Smart Citation

Program organization rather than choice of test determines success of cervical cancer screening: Case studies from Bangladesh and India

Bhatla

Nessa

Oswal

et al. 2020

Intl J Gynecology & Obste

View full text Add to dashboard Cite

The call for elimination of cervical cancer as a public health problem by the World Health Organization has led to intense focus on the burden of disease, available resources, and the possibility of introducing efficient systems for screening and treatment that allow effective cancer control in limited-resource settings. Presently, the focus is on the introduction of rapid, technologically less-demanding, affordable HPV testing. However, until such tests become widely available, the momentum that has been gained using visual inspection with acetic acid (VIA) should not be lost. Countries with limited resources and a heavy burden of cervical cancer, such as Bangladesh and India, introduced and scaled up VIA-based programs with varying degrees of programmatic organization and performance. Despite its limitations, VIA's simplicity and affordability has allowed these countries to build infrastructure, increase numbers of trained healthcare personnel, and develop a system of multilevel coordination within the health system. Such efforts will have long-term advantages provided that countries have access to an appropriate HPV test and build on their efforts to improve program organization through a strengthened health system, translating lessons learned in program implementation, logistics, and compliance with the new paradigm.

show abstract

Section: Cervical Cancer Burden and Trends In Bangladesh And Indiamentioning

confidence: 99%

Section: Cervical Cancer Burden and Trends In Bangladesh And Indiamentioning

confidence: 99%

Program organization rather than choice of test determines success of cervical cancer screening: Case studies from Bangladesh and India

Bhatla

Nessa

Oswal

et al. 2020

Intl J Gynecology & Obste

View full text Add to dashboard Cite

show abstract

“…Non-small-cell lung cancer (NSCLC) is the predominant form of lung cancer and one of cancer in the world with the highest incidence and mortality. [1][2][3] Distant metastasis, especially bone metastasis, is the main cause of death in patients. Moreover, bone metastasis can induce the multiple types of bone diseases to reduce the NSCLC patient's quality-of-life.…”

Section: Introductionmentioning

confidence: 99%

<p>Clinical Significance of Has_circ_0060937 in Bone Metastasis of NSCLC</p>

Zhang

Mao

Chen

et al. 2020

IJGM

View full text Add to dashboard Cite

Background Bone metastasis can induce multiple types of bone diseases which reduce the non-small-cell lung cancer (NSCLC) patient’s quality-of-life. Due to the difficulty of finding bone metastases and lack of effective early diagnosis, it is easy to miss the best treatment. Therefore, the study of serum tumor biomarkers is of great significance in the diagnosis of NSCLC bone metastasis. Methods The qRT-PCR assay was performed to assess has_circ_0060937 expression in 100 NSCLC patients. Furthermore, the small interfering RNAs si-has_circ_0060937 or si-NC were transfected into NSCLC bone metastasis cells. CCK8 assay was exercised to detect cell proliferation, and cell invasion assays were used to detect cell invasion in NSCLC bone metastasis cells. Results In this study, we firstly found that the expression of has_circ_0060937 in boneless metastasis NSCLC tissues and bone metastasis NSCLC tissues was significantly increased compared to normal tissues, and the expression of has_circ_0060937 was highest in bone metastasis. Expression of serum has_circ_0060937 in bone metastasis group from Grade I to Grade III NSCLC was drastically higher than boneless metastasis group or healthy group. In the Grade I to Grade III bone metastasis group, the expression of serum has_circ_0060937 gradually boosted with the increase of bone metastasis grades. Additionally, knockdown of has_circ_0060937 inhibited cell proliferation and cell invasion in NSCLC bone metastasis cell line. Conclusion The results suggestthat has_circ_0060937 is closely associated with bone metastasis in NSCLC, and the circRNAs we inspected may be a potential biomarker of bone metastasis in NSCLC.

show abstract

“…In India, NCDs were estimated to account for 63% of all deaths, and cancer was one of the leading causes (9%). (Mathur et al, 2020) On the other hand, those who have inished treatment, and those who are now cancer survivors are also facing multiple problems. Health-related stigma is increasingly recognised as a factor in luencing health promotion, disease prevention, and control.…”

Section: Introductionmentioning

confidence: 99%

Challenges and Opportunities for Breast Cancer Survivorship Care in India during Covid-19 Pandemic

Shinde¹,

Patil²

2020

ijrps

View full text Add to dashboard Cite

Breast cancer survivors faced challenges even during before COVID-19 era. During the pandemic era of COVID-19, breast cancer survivors represent a vulnerable population to various health problems, Psych-social disturbances and long term morbid consequences. The Indian Health care system is not fully prepared to deliver appropriate and quality care to non-COVID patients. The structural barriers to care are results in a pitiable condition, particularly for survivors living in rural areas. We reviewed the literature on cancer survivorship, Indian resources available and the challenges faced by breast cancer survivors. The current guidelines, standard operating procedures (SOP), Health care policies by Indian central government, state public health departments, non-government organisations, cancer treatment and research centres were analysed by data abstraction sheet. Multiple health governing agencies displayed general recommendations to modify the delivery of health care to minimise patient exposure to the virus. Minimal and limited health care resources are available for Breast Cancer survivors. As this pandemic continues the scientific evidence are expected regarding more specific recommendations and guidelines for survivorship care. Immediate efforts are required for addressing the needs of breast cancer survivors at present the development and implementation of policies for survivorship care. It is essential to implement interventions and policy for breast cancer survivors to mitigate the effects of this pandemic.

show abstract

Cancer Statistics, 2020: Report From National Cancer Registry Programme, India

Cited by 689 publications

References 22 publications

Program organization rather than choice of test determines success of cervical cancer screening: Case studies from Bangladesh and India

Program organization rather than choice of test determines success of cervical cancer screening: Case studies from Bangladesh and India

<p>Clinical Significance of Has_circ_0060937 in Bone Metastasis of NSCLC</p>

Challenges and Opportunities for Breast Cancer Survivorship Care in India during Covid-19 Pandemic

Contact Info

Product

Resources

About